Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ProMIS Neurosciences Q3 EPS $(0.24), Inline

Author: Benzinga Newsdesk | November 12, 2025 07:15am
ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.24) per share which met the analyst consensus estimate. This is a 177.42 percent decrease over earnings of $0.31 per share from the same period last year.

Posted In: PMN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist